Holen Sie sich die Stockscreener-App
19.60
4.42%
0.83
Handel nachbörslich:
19.21
-0.39
-1.99%
Schlusskurs vom Vortag:
$18.77
Offen:
$18.75
24-Stunden-Volumen:
3.76M
Relative Volume:
1.69
Marktkapitalisierung:
$1.68B
Einnahmen:
$17.49M
Nettoeinkommen (Verlust:
$-78.50M
KGV:
-16.33
EPS:
-1.2
Netto-Cashflow:
$-52.85M
1W Leistung:
+34.80%
1M Leistung:
+44.12%
6M Leistung:
+36.49%
1J Leistung:
+71.03%
1-Tages-Spanne:
$18.52
$19.76
1-Wochen-Bereich:
$14.42
$19.76
52-Wochen-Spanne:
$8.26
$19.76
Liquidia Corp Stock (LQDA) Company Profile
Firmenname
Liquidia Corp
Sektor
Branche
Telefon
919.328.4400
Adresse
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC
Vergleichen Sie LQDA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LQDA
Liquidia Corp
|
19.60 | 1.52B | 17.49M | -78.50M | -52.85M | -1.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 122.48B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 31.91B | 3.81B | -644.79M | -669.77M | -6.24 |
Liquidia Corp Stock (LQDA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-19 | Herabstufung | Oppenheimer | Perform → Underperform |
| 2024-12-20 | Eingeleitet | Wells Fargo | Overweight |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-08-19 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-08-16 | Eingeleitet | Raymond James | Outperform |
| 2024-06-25 | Eingeleitet | Oppenheimer | Perform |
| 2024-01-05 | Bestätigt | Needham | Buy |
| 2022-09-19 | Fortgesetzt | Wedbush | Underperform |
| 2022-09-01 | Herabstufung | Wedbush | Neutral → Underperform |
| 2022-07-22 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2022-05-31 | Eingeleitet | BTIG Research | Buy |
| 2022-05-26 | Eingeleitet | BofA Securities | Buy |
| 2020-12-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-11-20 | Herabstufung | Wedbush | Outperform → Neutral |
| 2018-11-08 | Fortgesetzt | Jefferies | Buy |
| 2018-09-05 | Eingeleitet | Wedbush | Outperform |
| 2018-08-20 | Eingeleitet | Jefferies | Buy |
| 2018-08-20 | Eingeleitet | Needham | Buy |
Alle ansehen
Liquidia Corp Aktie (LQDA) Neueste Nachrichten
Arquitos Capital Management Q2 2025 Investor Letter - Seeking Alpha
Why Liquidia Corporation stock attracts strong analyst attentionSafety First Trading Signals - Newser
Can Liquidia Corporation stock recover from recent declineLightning-fast capital gains - jammulinksnews.com
What analysts say about Liquidia Corporation stockSuperior investment outcomes - jammulinksnews.com
Liquidia Receives $50M from HCRx, Accelerates YUTREPIA’s Commercial Launch Following Favorable Court Ruling - MSN
Does Liquidia Corporation stock pay reliable dividendsTargeted 200 Percent Gain - Newser
Liquidia Corp: chief human resource officer Krepp sells $38k in stock - Investing.com India
Liquidia Corp: chief human resource officer Krepp sells $38k in stock By Investing.com - Investing.com South Africa
What makes Liquidia Corporation stock price move sharplyPredictable High Return Trades - Newser
How Liquidia Corporation stock performs during market volatility2x Return Forecast - Newser
When Can We Expect A Profit From Liquidia Corporation (NASDAQ:LQDA)? - simplywall.st
Liquidia's (NASDAQ:LQDA) growing losses don't faze investors as the stock rallies 12% this past week - Yahoo Finance
Liquidia Signs 70,000 SF Life Sciences Lease at Pathway Triangle in Morrisville, North Carolina - REBusinessOnline
DDC Raises ~$10.9M via 100-BTC Private Placement; Issues 10 % New Shares | LQDA SEC FilingForm 3 - Stock Titan
Liquidia Technologies Appoints Dana Boyle as Chief Accounting Officer - The Globe and Mail
Liquidia appoints Dana Boyle as chief accounting officer - Investing.com
What Next For Liquidia After Launch? (NASDAQ:LQDA) - Seeking Alpha
BTIG Adjusts Liquidia (LQDA) Price Target Amid Patent Trial | LQ - GuruFocus
BTIG Adjusts Liquidia (LQDA) Price Target Amid Patent Trial | LQDA Stock News - GuruFocus
Bearish Sentiment Surrounds Liquidia (LQDA) with Elevated Put Ac - GuruFocus
Liquidia Attacks UTC’s Tyvaso Drug Patent at Bench Trial Opening - Bloomberg Law News
Billion-dollar life sciences campus finally signs first tenant - The Business Journals
Liquidia leases space for manufacturing facility near headquarters - Business North Carolina
Liquidia Technologies Holds Annual Stockholders Meeting - TipRanks
Wells Fargo Raises Price Target for Liquidia (LQDA) to $25 | LQD - GuruFocus
Liquidia (LQDA): B of A Securities Lowers Price Target to $23 | LQDA Stock News - GuruFocus
# Raymond James reiterates Strong Buy on Liquidia stock amid competition - Investing.com
Liquidia (LQDA) Sees Surge in Options Activity Ahead of Earnings - GuruFocus
# Raymond James reiterates Strong Buy on Liquidia stock amid competition By Investing.com - Investing.com UK
Biotech Hits A 'Home Run' And Slams Its Two Key Rivals - Investor's Business Daily
Liquidia (LQDA) Sees Surge in Options Activity Ahead of Earnings | LQDA Stock News - GuruFocus
Phase II home run: Insmed’s TPIP hits hypertension endpoints - BioWorld MedTech
Treprostinil Saga Continues - JD Supra
Liquidia at Jefferies Conference: Strategic Moves in PAH Market - Investing.com
BTIG Raises Liquidia Price Target Following YUTREPIA Approval - Insider Monkey
Judge Denies UTC Bid To Block Liquidia's Lung Drug - Law360
Liquidia (LQDA) Stock Price Target Raised by Analyst | LQDA Stoc - GuruFocus
Raymond James maintains strong buy on Liquidia stock following court ruling By Investing.com - Investing.com South Africa
BTIG raises Liquidia stock price target following FDA approval By Investing.com - Investing.com South Africa
Raymond James maintains strong buy on Liquidia stock following court ruling - Investing.com India
BTIG raises Liquidia stock price target following FDA approval - Investing.com
Liquidia Beats UTC Bid to Block Launch of Lung Drug Yutrepia - Bloomberg Law News
Liquidia stock rises following YUTREPIA shipment news By Investing.com - Investing.com Canada
Liquidia stock rises following YUTREPIA shipment news - Investing.com
Needham raises Liquidia Technologies stock price target after court ruling By Investing.com - Investing.com South Africa
Finanzdaten der Liquidia Corp-Aktie (LQDA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Liquidia Corp-Aktie (LQDA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Schundler Russell | General Counsel |
Jul 14 '25 |
Sale |
14.28 |
7,836 |
111,898 |
577,977 |
| Saggar Rajeev | Chief Medical Officer |
Jul 14 '25 |
Sale |
14.28 |
5,327 |
76,070 |
271,413 |
| Moomaw Scott | Chief Commercial Officer |
Jul 14 '25 |
Sale |
14.28 |
4,797 |
68,501 |
223,231 |
| Krepp Sarah | Chief Human Resource Officer |
Jul 14 '25 |
Sale |
14.28 |
2,673 |
38,170 |
142,499 |
| Kaseta Michael | CFO and COO |
Jul 14 '25 |
Sale |
14.28 |
11,580 |
165,362 |
406,412 |
| JEFFS ROGER | Chief Executive Officer |
Jul 14 '25 |
Sale |
14.28 |
20,252 |
289,199 |
1,038,560 |
| JEFFS ROGER | Chief Executive Officer |
Jul 14 '25 |
Sale |
14.28 |
20,252 |
289,199 |
1,038,560 |
| Boyle Dana | Chief Accounting Officer |
Jul 14 '25 |
Sale |
14.28 |
1,193 |
17,036 |
187,168 |
| Adair Jason | Chief Business Officer |
Jul 14 '25 |
Sale |
14.28 |
2,576 |
36,785 |
193,634 |
| Schundler Russell | General Counsel |
Jun 04 '25 |
Sale |
16.97 |
8,460 |
143,566 |
582,054 |
0.97%
0.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):